Evaluation Of Linezolid Pk Profile In Burns Patients
NCT00255996 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2009-07-14
Summary
Evaluation of linezolid pk profile in burns patients
Conditions
- Burns
Interventions
- DRUG
-
linezolid
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-05-31
- Completion
- 2007-01-31
Countries
- France
Study Locations
More Related Trials
-
Linezolid in Healthy Volunteers
NCT03841721 ·Status: UNKNOWN ·Phase: PHASE1
-
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
NCT04983901 ·Status: COMPLETED ·Phase: PHASE2
-
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
NCT02439359 ·Status: COMPLETED ·Phase: PHASE1
-
Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal Infections
NCT06126263 ·Status: ACTIVE_NOT_RECRUITING
-
Population Pharmacokinetic-pharmacodynamic (PK-PD) Study of 9 Broad-Spectrum Anti-infective Agents in the Cerebro Spinal Fluid (CSF) of Brain Injured Patients With an External Ventricular Drainage (EVD).
NCT03481569 ·Status: COMPLETED ·Phase: PHASE1
-
Benznidazole Absorption, Metabolism and Excretion Study
NCT03739541 ·Status: COMPLETED ·Phase: PHASE1
-
A Study on the Prophylactic Use of Antibiotics Within 72 Hours After Acute Burn Injury in Patients
NCT06221761 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Linezolid on Ex Vivo Neutrophil and Monocyte Function in Healthy Males
NCT01544673 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.
NCT01875263 ·Status: TERMINATED ·Phase: PHASE3
-
Pharmacokinetics and Pharmacodynamics of Linezolid Continuous and Intermittent Administration
NCT05801484 ·Status: UNKNOWN ·Phase: NA
-
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
NCT02570490 ·Status: COMPLETED ·Phase: PHASE3
-
PCR Technic Evaluation in the Microbial Diagnostic of Septicemia in Hemodialysis Patients With Catheter.
NCT04026035 ·Status: COMPLETED
-
Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients
NCT01363271 ·Status: COMPLETED
-
Evaluation of Pharmacokinetic / Pharmacodynamic Data and Interest Individualized Therapeutic Drug Monitoring Glycopeptides and β-lactam-aminoglycoside ICU
NCT02846298 ·Status: UNKNOWN
-
Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection
NCT03747497 ·Status: COMPLETED ·Phase: PHASE2
-
Model-informed Precision Dosing for Linezolid
NCT06444802 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Evaluation of Pharmacokinetic / Pharmacodynamic and Tolerance Assessment of Dermal Administration of Beta-lactams in the Elderly
NCT02897648 ·Status: TERMINATED
-
Risk Factors for Linezolid Resistance in Staphylococcus Aureus
NCT00519025 ·Status: COMPLETED
-
Beta-lactams Therapeutic Drug Monitoring in Critically Ill Patients
NCT05352997 ·Status: COMPLETED
-
Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia
NCT03108690 ·Status: WITHDRAWN ·Phase: PHASE4
-
Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections
NCT00108433 ·Status: TERMINATED ·Phase: PHASE3
-
Addition of Probenecid to Penicillin-V Therapy
NCT05082909 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Linezolid or Vancomycin Surgical Site Infection Prophylaxis
NCT05571722 ·Status: RECRUITING ·Phase: PHASE4
-
Towards Reducing Resistance and Hematological Toxicity of Linezolid
NCT00177723 ·Status: COMPLETED
-
Pharmacological Study of High Doses of Ceftriaxone in Meningitidis
NCT01745679 ·Status: COMPLETED ·Phase: PHASE4